OTLK
Price
$1.60
Change
-$0.15 (-8.57%)
Updated
Jun 27 closing price
Capitalization
68.57M
STRO
Price
$0.73
Change
-$0.07 (-8.75%)
Updated
Jun 27 closing price
Capitalization
61.99M
38 days until earnings call
Interact to see
Advertisement

OTLK vs STRO

Header iconOTLK vs STRO Comparison
Open Charts OTLK vs STROBanner chart's image
Outlook Therapeutics
Price$1.60
Change-$0.15 (-8.57%)
Volume$2.91M
Capitalization68.57M
Sutro Biopharma
Price$0.73
Change-$0.07 (-8.75%)
Volume$11.76M
Capitalization61.99M
OTLK vs STRO Comparison Chart in %
Loading...
OTLK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
STRO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
OTLK vs. STRO commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OTLK is a Buy and STRO is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (OTLK: $1.60 vs. STRO: $0.73)
Brand notoriety: OTLK and STRO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: OTLK: 445% vs. STRO: 739%
Market capitalization -- OTLK: $68.57M vs. STRO: $61.99M
OTLK [@Biotechnology] is valued at $68.57M. STRO’s [@Biotechnology] market capitalization is $61.99M. The market cap for tickers in the [@Biotechnology] industry ranges from $304.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

OTLK’s FA Score shows that 0 FA rating(s) are green whileSTRO’s FA Score has 1 green FA rating(s).

  • OTLK’s FA Score: 0 green, 5 red.
  • STRO’s FA Score: 1 green, 4 red.
According to our system of comparison, STRO is a better buy in the long-term than OTLK.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

OTLK’s TA Score shows that 2 TA indicator(s) are bullish while STRO’s TA Score has 3 bullish TA indicator(s).

  • OTLK’s TA Score: 2 bullish, 4 bearish.
  • STRO’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, OTLK is a better buy in the short-term than STRO.

Price Growth

OTLK (@Biotechnology) experienced а -6.16% price change this week, while STRO (@Biotechnology) price change was -7.53% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Reported Earning Dates

STRO is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
OTLK($68.6M) has a higher market cap than STRO($62M). OTLK YTD gains are higher at: -15.344 vs. STRO (-60.109). OTLK has higher annual earnings (EBITDA): -76.83M vs. STRO (-203.18M). STRO has more cash in the bank: 249M vs. OTLK (7.56M). STRO has less debt than OTLK: STRO (21.4M) vs OTLK (33.3M). STRO has higher revenues than OTLK: STRO (66.4M) vs OTLK (0).
OTLKSTROOTLK / STRO
Capitalization68.6M62M111%
EBITDA-76.83M-203.18M38%
Gain YTD-15.344-60.10926%
P/E Ratio0.41N/A-
Revenue066.4M-
Total Cash7.56M249M3%
Total Debt33.3M21.4M156%
FUNDAMENTALS RATINGS
OTLK vs STRO: Fundamental Ratings
OTLK
STRO
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
85
Overvalued
27
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
6392
P/E GROWTH RATING
1..100
62100
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

STRO's Valuation (27) in the Pharmaceuticals Major industry is somewhat better than the same rating for OTLK (85) in the Biotechnology industry. This means that STRO’s stock grew somewhat faster than OTLK’s over the last 12 months.

STRO's Profit vs Risk Rating (100) in the Pharmaceuticals Major industry is in the same range as OTLK (100) in the Biotechnology industry. This means that STRO’s stock grew similarly to OTLK’s over the last 12 months.

STRO's SMR Rating (100) in the Pharmaceuticals Major industry is in the same range as OTLK (100) in the Biotechnology industry. This means that STRO’s stock grew similarly to OTLK’s over the last 12 months.

OTLK's Price Growth Rating (63) in the Biotechnology industry is in the same range as STRO (92) in the Pharmaceuticals Major industry. This means that OTLK’s stock grew similarly to STRO’s over the last 12 months.

OTLK's P/E Growth Rating (62) in the Biotechnology industry is somewhat better than the same rating for STRO (100) in the Pharmaceuticals Major industry. This means that OTLK’s stock grew somewhat faster than STRO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
OTLKSTRO
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 3 days ago
83%
Momentum
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bearish Trend 3 days ago
84%
Bearish Trend 3 days ago
89%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
84%
Bearish Trend 3 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
84%
Bearish Trend 3 days ago
88%
Advances
ODDS (%)
N/A
Bullish Trend 10 days ago
81%
Declines
ODDS (%)
Bearish Trend 3 days ago
83%
Bearish Trend 3 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
83%
Bullish Trend 3 days ago
90%
Aroon
ODDS (%)
N/A
Bearish Trend 3 days ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
OTLK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
STRO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
WRSLF0.090.01
+12.79%
Winsome Resources Ltd.
VEXTF0.120.01
+9.09%
Vext Science Inc.
CRPJF2.33N/A
N/A
China Resources Power Holdings Co., Ltd.
ELKEF2.15N/A
N/A
Elkem ASA
MIAPF10.68N/A
N/A
MINTO APT REAL ESTATE INVT TR

OTLK and

Correlation & Price change

A.I.dvisor tells us that OTLK and MCRB have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that OTLK and MCRB's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OTLK
1D Price
Change %
OTLK100%
-8.57%
MCRB - OTLK
32%
Poorly correlated
-4.31%
VIR - OTLK
31%
Poorly correlated
-2.64%
STRO - OTLK
30%
Poorly correlated
-8.14%
CRSP - OTLK
30%
Poorly correlated
N/A
ACXP - OTLK
29%
Poorly correlated
-10.25%
More

STRO and

Correlation & Price change

A.I.dvisor indicates that over the last year, STRO has been loosely correlated with TRDA. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if STRO jumps, then TRDA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To STRO
1D Price
Change %
STRO100%
-8.14%
TRDA - STRO
41%
Loosely correlated
-1.57%
ATXS - STRO
40%
Loosely correlated
N/A
DNLI - STRO
39%
Loosely correlated
-2.69%
TCRX - STRO
39%
Loosely correlated
-5.41%
PDSB - STRO
39%
Loosely correlated
-2.76%
More